GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,427,363 | -32.3% | 376,613 | -1.8% | 0.00% | -100.0% |
| Q2 2023 | $2,109,382 | +47.1% | 383,524 | +15.0% | 0.00% | – |
| Q1 2023 | $1,434,244 | +5.4% | 333,545 | -3.7% | 0.00% | – |
| Q4 2022 | $1,360,987 | -24.8% | 346,307 | +1.7% | 0.00% | -100.0% |
| Q3 2022 | $1,809,000 | -13.4% | 340,598 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $2,090,000 | -2.4% | 318,566 | +9.2% | 0.00% | 0.0% |
| Q1 2022 | $2,142,000 | -5.1% | 291,712 | -8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,256,000 | -70.5% | 318,575 | +4.5% | 0.00% | -50.0% |
| Q3 2021 | $7,644,000 | +46.5% | 304,905 | +57.3% | 0.00% | 0.0% |
| Q2 2021 | $5,216,000 | +0.5% | 193,894 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $5,189,000 | +121.6% | 182,325 | +120.7% | 0.00% | +100.0% |
| Q4 2020 | $2,342,000 | -6.2% | 82,604 | +2.3% | 0.00% | 0.0% |
| Q3 2020 | $2,497,000 | – | 80,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |